Cargando…

Simulating Transmission Scenarios of the Delta Variant of SARS-CoV-2 in Australia

An outbreak of the Delta (B.1.617.2) variant of SARS-CoV-2 that began around mid-June 2021 in Sydney, Australia, quickly developed into a nation-wide epidemic. The ongoing epidemic is of major concern as the Delta variant is more infectious than previous variants that circulated in Australia in 2020...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Sheryl L., Cliff, Oliver M., Zachreson, Cameron, Prokopenko, Mikhail
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907620/
https://www.ncbi.nlm.nih.gov/pubmed/35284395
http://dx.doi.org/10.3389/fpubh.2022.823043
_version_ 1784665689249808384
author Chang, Sheryl L.
Cliff, Oliver M.
Zachreson, Cameron
Prokopenko, Mikhail
author_facet Chang, Sheryl L.
Cliff, Oliver M.
Zachreson, Cameron
Prokopenko, Mikhail
author_sort Chang, Sheryl L.
collection PubMed
description An outbreak of the Delta (B.1.617.2) variant of SARS-CoV-2 that began around mid-June 2021 in Sydney, Australia, quickly developed into a nation-wide epidemic. The ongoing epidemic is of major concern as the Delta variant is more infectious than previous variants that circulated in Australia in 2020. Using a re-calibrated agent-based model, we explored a feasible range of non-pharmaceutical interventions, including case isolation, home quarantine, school closures, and stay-at-home restrictions (i.e., “social distancing.”) Our modelling indicated that the levels of reduced interactions in workplaces and across communities attained in Sydney and other parts of the nation were inadequate for controlling the outbreak. A counter-factual analysis suggested that if 70% of the population followed tight stay-at-home restrictions, then at least 45 days would have been needed for new daily cases to fall from their peak to below ten per day. Our model predicted that, under a progressive vaccination rollout, if 40–50% of the Australian population follow stay-at-home restrictions, the incidence will peak by mid-October 2021: the peak in incidence across the nation was indeed observed in mid-October. We also quantified an expected burden on the healthcare system and potential fatalities across Australia.
format Online
Article
Text
id pubmed-8907620
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-89076202022-03-11 Simulating Transmission Scenarios of the Delta Variant of SARS-CoV-2 in Australia Chang, Sheryl L. Cliff, Oliver M. Zachreson, Cameron Prokopenko, Mikhail Front Public Health Public Health An outbreak of the Delta (B.1.617.2) variant of SARS-CoV-2 that began around mid-June 2021 in Sydney, Australia, quickly developed into a nation-wide epidemic. The ongoing epidemic is of major concern as the Delta variant is more infectious than previous variants that circulated in Australia in 2020. Using a re-calibrated agent-based model, we explored a feasible range of non-pharmaceutical interventions, including case isolation, home quarantine, school closures, and stay-at-home restrictions (i.e., “social distancing.”) Our modelling indicated that the levels of reduced interactions in workplaces and across communities attained in Sydney and other parts of the nation were inadequate for controlling the outbreak. A counter-factual analysis suggested that if 70% of the population followed tight stay-at-home restrictions, then at least 45 days would have been needed for new daily cases to fall from their peak to below ten per day. Our model predicted that, under a progressive vaccination rollout, if 40–50% of the Australian population follow stay-at-home restrictions, the incidence will peak by mid-October 2021: the peak in incidence across the nation was indeed observed in mid-October. We also quantified an expected burden on the healthcare system and potential fatalities across Australia. Frontiers Media S.A. 2022-02-24 /pmc/articles/PMC8907620/ /pubmed/35284395 http://dx.doi.org/10.3389/fpubh.2022.823043 Text en Copyright © 2022 Chang, Cliff, Zachreson and Prokopenko. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Public Health
Chang, Sheryl L.
Cliff, Oliver M.
Zachreson, Cameron
Prokopenko, Mikhail
Simulating Transmission Scenarios of the Delta Variant of SARS-CoV-2 in Australia
title Simulating Transmission Scenarios of the Delta Variant of SARS-CoV-2 in Australia
title_full Simulating Transmission Scenarios of the Delta Variant of SARS-CoV-2 in Australia
title_fullStr Simulating Transmission Scenarios of the Delta Variant of SARS-CoV-2 in Australia
title_full_unstemmed Simulating Transmission Scenarios of the Delta Variant of SARS-CoV-2 in Australia
title_short Simulating Transmission Scenarios of the Delta Variant of SARS-CoV-2 in Australia
title_sort simulating transmission scenarios of the delta variant of sars-cov-2 in australia
topic Public Health
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907620/
https://www.ncbi.nlm.nih.gov/pubmed/35284395
http://dx.doi.org/10.3389/fpubh.2022.823043
work_keys_str_mv AT changsheryll simulatingtransmissionscenariosofthedeltavariantofsarscov2inaustralia
AT cliffoliverm simulatingtransmissionscenariosofthedeltavariantofsarscov2inaustralia
AT zachresoncameron simulatingtransmissionscenariosofthedeltavariantofsarscov2inaustralia
AT prokopenkomikhail simulatingtransmissionscenariosofthedeltavariantofsarscov2inaustralia